ReviewCurrent pharmaceutical design2015

Targeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational Biomarker.

Kenji HashimotoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.